R&D Big promises, hard work: What 2026 will demand from pharma Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.
Market Access Nine for 2023, part one: a reflection on inflection The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one.
News Sanofi reported to be looking at an Insmed takeover Sanofi CEO Belén Garijo has said she wants to make M&A deals, and the rumour mill is now linking the French group to a possible takeover of Insmed.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.